Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder

Psychosomatic Medicine

Volumn 66, Issue 3, 2004, Pages 403-410

  Girdler, Susan S ^a,b   Thompson, Kate S ^b   Light, Kathleen C ^a,b   Leserman, Jane ^a   Pedersen, Cort A ^a   Prange Jr , Arthur J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Menstrual cycle; Premenstrual dysphoric disorder; Sexual abuse; Thyroid axis hormones

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN;

ADULT; AGED; ANGER; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLICULAR PHASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; LUTEAL PHASE; OVARY CYCLE; PATHOPHYSIOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; SEXUAL ABUSE;

ADOLESCENT; ADULT; AROUSAL; CHILD; CHILD ABUSE, SEXUAL; FEMALE; FOLLICULAR PHASE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEAL PHASE; PITUITARY-ADRENAL SYSTEM; PREMENSTRUAL SYNDROME; SEX OFFENSES; THYROID HORMONES; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 2442661477     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000127690.38525.ab     Document Type: Article

References (37)

1. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
2. Rubinow DR, Schmidt PJ. Premenstrual syndrome: a review of endocrine studies. Endocrinologist 1992;2:47-54.
3. Korzekwa MI, Lamon JA, Steiner M. Late luteal phase dysphoric disorder and the thyroid axis revisited. J Clin Endocrinol Metab 1996;81: 2280-4.
4. Pearlstein TB, Frank E, Rivera-Tova A, Thoft JS, Jacobs E, Mieczkowski TA. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990;20:129-34.
5. Prange AJ Jr, Loosen PT, Wilson IC, Lipton MA. The therapeutic use of hormones of the thyroid axis in depression. In: Post RM, Ballenger JC, editors. Neurobiology of mood disorders. Baltimore and London: Williams & Wilkins; 1984:311-22.
6. Kirkegaard C, Faber J. Free thyroxine and 3,3α,5α -triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol (Copenh) 1991;124:166-72.
7. Stem RA, Prange AJ Jr. Neuropsychiatric aspects of endocrine disorders. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 6th ed. Baltimore and London: Williams & Wilkins; 1993:663-77.
8. Nikolai TF, Mulligan GM, Gribble RK, Harkins PG, Meiere PR, Roberts RC. Thyroid function and treatment in premenstrual syndrome. J Clin Endorcrinol Metab 1990;70:1108-13.
9. Casper RF, Ptel-Christopher A, Powell A. Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab 1989;68:608-12.
10. Roy-Byrne PP, Rubinow DR, Hoban MC, Grover GN, Blank D. TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 1987;144:480-4.
11. Schmidt PJ, Grover GN, Roy-Byrne PP, Rubinow DR. Thyroid function in women with premenstrual syndrome. J Clin Endocrinol Metab 1993; 76:671-4.
12. Girdler SS, Pedersen CA, Light KC. Thyroid axis function during the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 1995;20:395-403.
13. Mason JW. A review of psychoendocrine research on the pituitarythyroid system. Psychosom Med 1968;30:666-81.
14. Golding JM, Taylor DL. Sexual assault history and premenstrual distress in two general population samples. J Womens Health 1996;5:143-52.
15. Golding JM, Taylor DL, Menard L, King MJ. Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychosom Obstet Gynecol 2000;21:69-80.
16. Paddison PL, Gise LH, Lebovits A, Strain JJ, Cirasole DM, Levine JP. Sexual abuse and premenstrual syndrome: comparison between a lower and higher socioeconomic group. Psychosom Med 1990;31:265-72.
17. Mason J, Weizman R, Laorm N, Wang S, Schujovitsky A, Abramovitz-Schneider P, Feiler D, Charney D. Serum triiodothyronine elevation in Israeli combat veterans with posttraumatic stress disorder: a cross-cultural study. Biol Psychiatry 1996;39:835-8.
18. Mason J, Southwick S, Yehuda R, Wang S, Riney S, Bremner D, Johnson D, Lubin H, Blake D, Zhou G, Gusman F, Charney D. Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1994;51:629-41.
19. 3 levels and their association with symptoms in World War 11 veterans with combat-related posttraumatic stress disorder: replication of findings in Vietnam combat veterans. Psychosom Med 1999;61:131-8.
20. Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, Pedersen CA, Light KC. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 2003;65:849-56.
21. American Psychiatric Association. DSM-III-revised: diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Press; 1987.
22. Reid RL. Premenstrual syndrome. In: Leventhal JM, Hoffman JJ, Keith LG, Taylor PJ, editors. Obstetrics, gynecology and fertility. Chicago: Year Book Medical Publishers; 1985:4-57.
23. Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med 1996;58:4-15.
24. Hathaway SR, McKinley JC. MMP1-2: Minnesota Multiphasic Personality Inventory - 2: manual for administration and scoring. Minneapolis: University of Minnesota Press; 1989.
25. National Institutes of Health. Recruitment and retention of women in clinical studies. 1993. NIH Publication No. 95-3756:1-104.
26. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001;49:788-97.
27. Same DH, Refetoff S, Rosenfield RL, Farriaux JP. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab 1988;66:740-6.
28. De Bellis MD, Burke L, Trickett PK, Putnam FW. Antinuclear antibodies and thyroid function in sexually abused girls. J Trauma Stress 1996;9: 369-78.
29. Stein MB, Barrett-Connor E. Sexual assault and physical health: findings from a population-based study of older adults. Psychosom Med 2002;62: 834-43.
30. Prange AJ Jr. Thyroid axis sustaining hypothesis of posttraumatic stress disorder. Psychosom Med 1999;61:139-40.
31. Hollander CS, Mitsuma T, Shenkman L, Woolf P, Gershengorn MC. Thyrotropin-releasing hormone: evidence for thyroid response to intravenous injection in man. Science 1972;175:209-19.
32. Mason GA, Bondy SC, Nemeroff CB, Walker CH, Prange AJ Jr. The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology 1987;12:261-70.
33. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 1991;61: 984-91.
34. Hegedus L, Karstrup S, Rasmussen N. Evidence of cycle alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 1986;155:142-5.
35. Beck RP, Fawcett DM, Morcos F. Thyroid function studies in different phases of the menstrual cycle and in women receiving norethindrone with and without estrogen. Am J Obstet Gynecol 1972;112:369-73.
36. Nilsson OR, Melander A, Tegler L. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. Eur J Clin Pharmacol 1980;18:315-20.
37. Diegoli MSC, da Fonseca AM, Diegoli CA, Pinotti JA. A double-blind trial of 4 medications to treat severe premenstrual syndrome. Int J Gynecol Obstet 1998;62:63-7.